{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:47:04Z","timestamp":1769356024504,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funds for Statutory Activity of Medical University of Lublin"},{"name":"Maria Curie-Sk\u0142odowska University, Lublin, Poland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pharep.2014.06.016","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T00:50:44Z","timestamp":1404262244000},"page":"1031-1036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice"],"prefix":"10.1007","volume":"66","author":[{"given":"Ewa","family":"Poleszak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Wo\u015bko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Kasperek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"Dudka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Wr\u00f3bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2014.06.016_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0010","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/j.neubiorev.2012.12.007","article-title":"The neurobiology of depression and antidepressant action","volume":"37","author":"Willner","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharep.2014.06.016_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pharep.2014.06.016_bib0020","series-title":"Frontiers in Neuroscience","article-title":"Pharmacology of NMDA receptors","author":"Monaghan","year":"2009"},{"key":"10.1016\/j.pharep.2014.06.016_bib0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0165-6147(90)90150-7","article-title":"The behavioral pharmacology of NMDA receptor antagonists","volume":"11","author":"Willetts","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2014.06.016_bib0030","series-title":"Biology of the NMDA receptor","article-title":"Extracellular modulation of NMDA receptors","author":"Williams","year":"2009"},{"key":"10.1016\/j.pharep.2014.06.016_bib0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/WNF.0b013e3180314ae7","article-title":"An open-label, flexible-dose study of memantine in major depressive disorder","volume":"30","author":"Ferguson","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0045","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4088\/JCP.v69n0308","article-title":"Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence","volume":"69","author":"Muhonen","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/0253-7176.127258","article-title":"Acute antidepressant effects of intramuscular versus intravenous ketamine","volume":"36","author":"Chilukuri","year":"2014","journal-title":"Indian J Psychol Med"},{"key":"10.1016\/j.pharep.2014.06.016_bib0065","first-page":"10","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/0019-5545.64573","article-title":"Innovative approaches to treatment \u2013 refractory depression: the ketamine story","volume":"52","author":"Rao","year":"2010","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0075","first-page":"703","article-title":"Effect of joint administration of imipramine and amantadine on binding of [3H]7-OH-DPAT to dopamine D3 receptors in peripheral blood lymphocytes of the patients with drug-resistant unipolar depression","volume":"54","author":"Dziedzicka-Wasylewska","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0080","first-page":"778","article-title":"Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression","volume":"59","author":"Rog\u00f3\u017c","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2014.06.016_bib0085","first-page":"1143","article-title":"Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study","volume":"55","author":"Nowak","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2009.02.014","article-title":"Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study","volume":"118","author":"Siwek","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharep.2014.06.016_bib0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00213-009-1609-1","article-title":"NMDA receptor\/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test","volume":"206","author":"Ghasemi","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2014.06.016_bib0100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.06.001","article-title":"Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice","volume":"46","author":"Poleszak","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0105","first-page":"4","article-title":"Pharmacology of antidepressants: selectivity or multiplicity?","volume":"60","author":"Westenberg","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. B","key":"10.1016\/j.pharep.2014.06.016_bib0110","first-page":"9","article-title":"Clinical overview of serotonin reuptake inhibitors","volume":"51","author":"Rickels","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0115","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4088\/JCP.v60n0610","article-title":"a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder","volume":"60","author":"Versiani","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.pharep.2014.06.016_bib0120","first-page":"S32","article-title":"Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase","volume":"11","author":"Mocaer","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0125","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00702-011-0630-9","article-title":"A complex interaction between glycine\/NMDA receptors and serotonergic\/noradrenergic antidepressants in the forced swim test in mice","volume":"118","author":"Poleszak","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharep.2014.06.016_bib0130","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S1734-1140(11)70716-2","article-title":"NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice","volume":"63","author":"Wla\u017a","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2014.06.016_bib0135","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2014.06.016_bib0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0924-977X(92)90034-6","article-title":"Effects of MK-801 and antidepressant drugs in the forced swimming test in rats","volume":"2","author":"Maj","year":"1992","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0145","first-page":"217","article-title":"The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats","volume":"44","author":"Maj","year":"1992","journal-title":"Pol J Pharmacol Pharm"},{"key":"10.1016\/j.pharep.2014.06.016_bib0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1358\/mf.2010.32.2.1481727","article-title":"The effect of the NMDA receptor antagonist dizocilpine on behavioral manifestations of serotonin and adrenergic antidepressants in rats","volume":"32","author":"Pruus","year":"2010","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(90)90204-J","article-title":"Functional antagonists at the NMDA receptor complex exhibit antidepressant actions","volume":"185","author":"Trullas","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0160","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0028-3908(02)00055-2","article-title":"Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats","volume":"42","author":"Rog\u00f3\u017c","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2014.06.016_bib0165","first-page":"179","article-title":"Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies","volume":"56","author":"Rog\u00f3\u017c","year":"2004","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0170","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1734-1140(09)70167-7","article-title":"Effect of co-administration of fluoxetine and amantadine on immunoendocrine parameters in rats subjected to a forced swimming test","volume":"61","author":"Rog\u00f3\u017c","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2014.06.016_bib0175","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.pnpbp.2008.09.006","article-title":"Interaction of zinc with antidepressants in the tail suspension test","volume":"32","author":"Cunha","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0180","first-page":"681","article-title":"Interaction of zinc with antidepressants in the forced swimming test in mice","volume":"54","author":"Szewczyk","year":"2002","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2014.06.016_bib0185","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pnpbp.2008.12.011","article-title":"The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test","volume":"33","author":"Szewczyk","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0190","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00702-007-0714-8","article-title":"Modulation of antidepressant-like activity of magnesium by serotonergic system","volume":"114","author":"Poleszak","year":"2007","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharep.2014.06.016_bib0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharep.2014.06.016_bib0200","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0306-4522(03)00380-4","article-title":"Repeated administration of antidepressants decreases field potentials in rat frontal cortex","volume":"120","author":"Bobula","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2014.06.016_bib0205","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0022-3565(25)38235-2","article-title":"Adaptive changes in the N-methyl-d-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid","volume":"265","author":"Nowak","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2014.06.016_bib0210","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/S0028-3908(00)00090-3","article-title":"Chronic treatment with antidepressants affects glycine\/NMDA receptor function: behavioral evidence","volume":"39","author":"Popik","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2014.06.016_bib0215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3565(25)38715-X","article-title":"Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments","volume":"269","author":"Paul","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2014.06.016_bib0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2007-979537","article-title":"Adaptation of N-methyl-d-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression","volume":"29","author":"Skolnick","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0225","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0006-8993(97)00568-4","article-title":"(MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats","volume":"765","author":"Yan","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2014.06.016_bib0230","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02761776","article-title":"Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study","volume":"10","author":"Boyer","year":"1998","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.pharep.2014.06.016_bib0235","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.biopsych.2007.04.014","article-title":"Direct inhibitory effect of fluoxetine on N-methyl-d-aspartate receptors in the central nervous system","volume":"62","author":"Szasz","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0240","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuint.2011.12.005","article-title":"GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine","volume":"60","author":"Kiss","year":"2012","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharep.2014.06.016_bib0245","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0006-3223(99)00291-7","article-title":"Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor","volume":"47","author":"Wong","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2014.06.016_bib0250","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S1734-1140(13)71080-6","article-title":"Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test","volume":"65","author":"Wolak","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2014.06.016_bib0255","doi-asserted-by":"crossref","first-page":"e37989","DOI":"10.1371\/journal.pone.0037989","article-title":"Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors","volume":"7","author":"Ishima","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2014.06.016_bib0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2014.06.016_bib0265","first-page":"588","article-title":"Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action","volume":"60","author":"Szewczyk","year":"2008","journal-title":"Pharmacol Rep"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:36Z","timestamp":1752611736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.06.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1734114014002278"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.06.016","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}